Promoting Immune Regulation in Type 1 Diabetes Using Low-Dose Interleukin-2
Current Diabetes Reports - United States
doi 10.1007/s11892-016-0739-1
Full Text
Open PDFAbstract
Available in full text
Date
April 13, 2016
Authors
Publisher
Springer Science and Business Media LLC